Thermo Fisher Scientific
-
Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics
Enhanced platform technology and the addition of a robust, high-quality CHO K-1 cell line decreases lead time to…
-
Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research
The Thermo Scientific™ Stellar™ mass spectrometer combines speed and sensitivity to advance precision medicine.
-
Thermo Fisher Scientific Launches New CXCL10 Testing Service
Noninvasive urine-based biomarker testing can support routine testing for graft dysfunction
-
Thermo Fisher Scientific Announces Latest Round of Oncomine Clinical Research Grant Awardees
Recipients’ research focused on melanoma diagnosis, treatment response in advanced NSCLC, and bypassing common hurdles in NSCLC diagnosis…
-
Thermo Fisher Scientific Recognized by Customers for Contract Manufacturing Leadership
Pharma and biotech customers distinguish excellence in capabilities, compatibility, expertise, quality and reliability
-
Thermo Fisher Scientific Receives GMP approval from the Italian Medicines Agency (AIFA) for its Manufacturing facility of RNA-Based Products in Monza, Italy
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients.
-
Thermo Fisher Scientific Unveils Industry’s First Off-the-Shelf Validated Software Solution to Automate Cell Therapy Manufacturing Workflows
Gibco CTS Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate…
-
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics
Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions
-
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies
Thermo Fisher Scientific Opens Cell Therapy Facility at UCSF to Accelerate Development of Breakthrough Therapies
-
Thermo Fisher Scientific Expands in Utah with New Bioprocessing Manufacturing Site in Ogden
Company now employs more than 2,000 people state-wide across three locations
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
